Epitalon (Epithalon)
Synthetic Pineal Tetrapeptide · Telomerase Activator
Overview
Epitalon is a synthetic tetrapeptide developed by Russian scientist Vladimir Khavinson with 35+ years of research. It activates telomerase at extremely low concentrations to maintain telomere length, stimulates melatonin production, and modulates gene expression through epigenetic mechanisms.
Activates telomerase at extremely low concentrations (10⁻¹⁷ to 10⁻¹⁵ M) to maintain telomere length, stimulates melatonin production from the pineal gland, and modulates gene expression through epigenetic mechanisms.
Activates telomerase at microgram doses to extend telomeres and cellular replicative lifespan.
Reverses aging markers and improves mitochondrial function at the cellular level.
Animal studies show 25-33% lifespan increases using 30-40mcg/kg doses.
Restores pineal gland function and circadian melatonin rhythm in elderly.
Mechanism
Epitalon is a synthetic tetrapeptide developed by Russian scientist Vladimir Khavinson with 35+ years of research. It activates telomerase at extremely low concentrations to maintain telomere length, stimulates melatonin production, and modulates gene expression through epigenetic mechanisms.
Activates telomerase at extremely low concentrations (10⁻¹⁷ to 10⁻¹⁵ M) to maintain telomere length, stimulates melatonin production from the pineal gland, and modulates gene expression through epigenetic mechanisms.
Activates telomerase at microgram doses to extend telomeres and cellular replicative lifespan.
Research areas
- Epitalon is a synthetic tetrapeptide developed by Russian scientist Vladimir Khavinson with 35+ years of research. It activates telomerase at extremely low concentrations to maintain telomere length, stimulates melatonin production, and modulates gene expression through epigenetic mechanisms.
- Activates telomerase at extremely low concentrations (10⁻¹⁷ to 10⁻¹⁵ M) to maintain telomere length, stimulates melatonin production from the pineal gland, and modulates gene expression through epigenetic mechanisms.
- Activates telomerase at microgram doses to extend telomeres and cellular replicative lifespan.
- Reverses aging markers and improves mitochondrial function at the cellular level.
- Animal studies show 25-33% lifespan increases using 30-40mcg/kg doses.
- Restores pineal gland function and circadian melatonin rhythm in elderly.
- Supports new neuron formation at nanogram concentrations.
- 90% response rate for retinal degeneration at 5mcg per eye dosing.
- Supports thymus gland regeneration for improved immune function.
- Enhanced immune surveillance and countering of immunosenescence.
- Source: Published Clinical Studies
- "Use doses validated in peer-reviewed human research"
- Based on actual human clinical trials, including a study of 75 women using 0.5mg/day sublingually for 20 days. Animal studies typically used 0.1-10mcg/mouse/day. This approach prioritizes evidence-based dosing over anecdotal community protocols.
- 0.5-1mg daily (10-20x lower than community protocols)
- Supported by peer-reviewed human clinical data
- 20-day cycle length from clinical trials
- More economical per cycle
- Aligns with research showing microgram-level efficacy
Research notes
- Generally well-tolerated with minimal side effects
- Mild injection site reactions
- Vivid dreams (melatonin-related)
- Possible mild digestive upset (oral route)
- Signs of allergic reaction
- Persistent injection site inflammation
- New or changing moles (monitor skin)
- Cancer diagnosis (discontinue immediately)
- Unusual fatigue or weakness
- Active malignancy (telomerase activation concern)
- Chronic sinusitis (nasal route)
- Known peptide allergies
- Pregnancy or breastfeeding
- Effects persist for months after a 10-20 day cycle due to epigenetic changes in gene expression and sustained telomerase activity. Many users repeat cycles 2-3 times yearly with 4-6 month breaks, allowing the body to maintain benefits from each cycle while avoiding continuous stimulation.
Protocol Variations
- Multiple approaches exist - compare before choosing
- Different sources recommend different protocols for this peptide. Review each approach and consider your goals, tolerance, and experience level before choosing.
High-Dose Community Protocol
- Source: Biohacking Communities
- "Higher doses for potentially stronger effects"
- Widely circulated protocol recommending 5-10mg daily injections. This dosing lacks peer-reviewed human clinical data and may stem from translation errors of Russian research or extrapolation from other peptides. No published studies validate this dose range in humans.
- 5-10mg daily (10-20x higher than research protocols)
- No peer-reviewed human data at these doses
- Significantly more expensive per cycle
- Unknown if higher doses provide additional benefit
- May have originated from translation errors
AXIOM catalogue
Epitalon — research-use catalogue record with strengths and available batch details where listed.
References
- pubmed.ncbi.nlm.nih.gov/12195242/
- pubmed.ncbi.nlm.nih.gov/12937682/
- pubmed.ncbi.nlm.nih.gov/11524632/
- pubmed.ncbi.nlm.nih.gov/32019204/
- pubmed.ncbi.nlm.nih.gov/14501183/
- pubmed.ncbi.nlm.nih.gov/14523363/
FAQs
What's the correct Epitalon dosage—why do some sources recommend 5-10mg versus 0.5-1mg?
Peer-reviewed human clinical trials show efficacy at 0.5-1mg daily, while many community protocols recommend 5-10mg based on what appears to be translation errors from animal studies. Original research demonstrates microgram-level activation of telomerase, making lower doses research-supported. Higher doses lack human validation and are significantly more expensive.
Does Epitalon really extend lifespan or is that just animal studies?
Animal studies show 25-33% lifespan extension with Epitalon, and a 6-8 year clinical trial of 266 elderly subjects found a 1.6-1.8 fold mortality reduction with Epithalamin. While impressive, human lifespan extension claims remain theoretical. Effects on cellular aging markers like telomere length are better documented than actual longevity in humans.